No Data
Champions Oncology (NASDAQ:CSBR) Shareholders Have Endured a 61% Loss From Investing in the Stock Three Years Ago
Champions Oncology Announces Agreement With Weill Cornell Medicine
Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ...
Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Champions Oncology Announces Sudden Loss of President
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business
No Data
No Data